{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:51:58Z","timestamp":1762606318024},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,8,31]],"date-time":"2013-08-31T00:00:00Z","timestamp":1377907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s10554-013-0285-8","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T05:35:40Z","timestamp":1377840940000},"page":"1693-1703","source":"Crossref","is-referenced-by-count":19,"title":["Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial"],"prefix":"10.1007","volume":"29","author":[{"given":"Pasi","family":"Karjalainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,31]]},"reference":[{"key":"285_CR1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"GW Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221\u2013231","journal-title":"N Engl J Med"},{"key":"285_CR2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen J, Wenaweser P, Tsuchida K et al (2007) Early and late coronary stent thrombosis of sirolimus eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369:667\u2013678","journal-title":"Lancet"},{"key":"285_CR3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner M, Finn AV, Farb A et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193\u2013202","journal-title":"J Am Coll Cardiol"},{"key":"285_CR4","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","volume":"115","author":"AV Finn","year":"2007","unstructured":"Finn AV, Joner M, Nakazawa G et al (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435\u20132441","journal-title":"Circulation"},{"key":"285_CR5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/eurheartj\/ehp433","volume":"31","author":"F Prati","year":"2010","unstructured":"Prati F, Regar E, Mintz GS et al (2010) Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 31:401\u2013415","journal-title":"Eur Heart J"},{"key":"285_CR6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/hrt.2010.204594","volume":"97","author":"K Fujii","year":"2011","unstructured":"Fujii K, Kawasaki D, Oka K et al (2011) Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart 97:977\u2013982","journal-title":"Heart"},{"key":"285_CR7","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jacc.2009.01.051","volume":"53","author":"JW Kim","year":"2009","unstructured":"Kim JW, Seo HS, Park JH et al (2009) A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus-versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction. J Am Coll Cardiol 53:1653\u20131659","journal-title":"J Am Coll Cardiol"},{"key":"285_CR8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/CIRCINTERVENTIONS.108.821371","volume":"2","author":"J Obata","year":"2009","unstructured":"Obata J, Nakamura T, Kitta Y et al (2009) Treatment of acute myocardial infarction with sirolimus-eluting stents results in chronic endothelial dysfunction in the infarct-related coronary artery. Circ Cardiovasc Interv 2:384\u2013391","journal-title":"Circ Cardiovasc Interv"},{"key":"285_CR9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4244\/EIJV8I3A49","volume":"8","author":"PP Karjalainen","year":"2012","unstructured":"Karjalainen PP, Niemel\u00e4 M, Airaksinen JK et al (2012) A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial. EuroIntervention 8:306\u2013315","journal-title":"EuroIntervention"},{"key":"285_CR10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.amjcard.2006.01.031","volume":"97","author":"T Kume","year":"2006","unstructured":"Kume T, Akasaka T, Kawamoto T et al (2006) Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 97:1713\u20131717","journal-title":"Am J Cardiol"},{"key":"285_CR11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1475-097X.2008.00794.x","volume":"28","author":"T Kiviniemi","year":"2008","unstructured":"Kiviniemi T (2008) Assessment of coronary blood flow and the reactivity of the microcirculation non-invasively with transthoracic echocardiography. Clin Physiol Funct Imaging 28:145\u2013155","journal-title":"Clin Physiol Funct Imaging"},{"key":"285_CR12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ultrasmedbio.2006.08.012","volume":"33","author":"TO Kiviniemi","year":"2007","unstructured":"Kiviniemi TO, Toikka JO, Koskenvuo JW et al (2007) Vasodilation of epicardial coronary artery can be measured with transthoracic echocardiography. Ultrasound Med Biol 33:362\u2013370","journal-title":"Ultrasound Med Biol"},{"key":"285_CR13","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1253\/circj.CJ-08-1166","volume":"73","author":"D Murakami","year":"2009","unstructured":"Murakami D, Takano M, Yamamoto M et al (2009) Advanced neointimal growth is not associated with a low risk of in-stent thrombus. Optical coherence tomographic findings after first-generation drug-eluting stent implantation. Circ J 73:1627\u20131634","journal-title":"Circ J"},{"key":"285_CR14","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1136\/hrt.2009.167759","volume":"95","author":"JS Kim","year":"2009","unstructured":"Kim JS, Jang IK, Kim TH et al (2009) Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart 95:1907\u20131912","journal-title":"Heart"},{"key":"285_CR15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1253\/circj.CJ-08-0746","volume":"73","author":"H Katoh","year":"2009","unstructured":"Katoh H, Shite J, Shinke T et al (2009) Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J 73:1033\u20131037","journal-title":"Circ J"},{"key":"285_CR16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijcard.2009.07.012","volume":"146","author":"JS Kim","year":"2011","unstructured":"Kim JS, Fan C, Choi D et al (2011) Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study. Int J Cardiol 146:341\u2013346","journal-title":"Int J Cardiol"},{"key":"285_CR17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1253\/circj.CJ-09-0546","volume":"74","author":"JS Kim","year":"2010","unstructured":"Kim JS, Kim TH, Fan C et al (2010) Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9\u00a0months after implantation. Circ J 74:320\u2013326","journal-title":"Circ J"},{"key":"285_CR18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jcin.2009.01.010","volume":"2","author":"P Moore","year":"2009","unstructured":"Moore P, Barlis P, Spiro J et al (2009) A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents. JACC Cardiovasc Interv 2:437\u2013444","journal-title":"JACC Cardiovasc Interv"},{"key":"285_CR19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/eurheartj\/ehp480","volume":"31","author":"P Barlis","year":"2010","unstructured":"Barlis P, Regar E, Serruys PW et al (2010) An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J 31:165\u2013176","journal-title":"Eur Heart J"},{"key":"285_CR20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ahj.2009.11.029","volume":"159","author":"JS Kim","year":"2010","unstructured":"Kim JS, Hong MK, Fan C et al (2010) Intracoronary thrombus formation after drug-eluting stents implantation: optical coherence tomographic study. Am Heart J 159:278\u2013283","journal-title":"Am Heart J"},{"key":"285_CR21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.acvd.2009.05.010","volume":"102","author":"P Motreff","year":"2009","unstructured":"Motreff P, Souteyrand G, Levesque S et al (2009) Comparative analysis of neointimal coverage with paclitaxel and zotarolimus drug-eluting stents, using optical coherence tomography 6\u00a0months after implantation. Arch Cardiovasc Dis 102:617\u2013624","journal-title":"Arch Cardiovasc Dis"},{"key":"285_CR22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/CIRCINTERVENTIONS.110.950154","volume":"3","author":"G Guagliumi","year":"2010","unstructured":"Guagliumi G, Sirbu V, Musumeci G et al (2010) Strut coverage and vessel wall response to a new generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: optical coherence tomography drug-eluting stent investigation (OCTDESI). Circ Cardiovasc Interv 3:367\u2013375","journal-title":"Circ Cardiovasc Interv"},{"key":"285_CR23","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1093\/eurheartj\/ehr182","volume":"32","author":"JL Guti\u00e9rrez-Chico","year":"2011","unstructured":"Guti\u00e9rrez-Chico JL, van Geuns RJ, Regar E et al (2011) Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial. Eur Heart J 32:2454\u20132463","journal-title":"Eur Heart J"},{"key":"285_CR24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcin.2010.04.005","volume":"3","author":"G Guagliumi","year":"2010","unstructured":"Guagliumi G, Sirbu V, Bezerra H et al (2010) Strut coverage and vessel wall response to zotarolimus eluting and bare-metal stents implanted in patients with st-segment elevation myocardial infarction: the OCTAMI (optical coherence tomography in acute myocardial infarction) study. JACC Cardiovasc Interv 3:680\u2013687","journal-title":"JACC Cardiovasc Interv"},{"key":"285_CR25","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4244\/EIJV6I5A95","volume":"6","author":"J Fajadet","year":"2010","unstructured":"Fajadet J, Wijns W, Laarman GJ et al (2010) Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study. EuroIntervention 6:562\u2013567","journal-title":"EuroIntervention"},{"key":"285_CR26","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1161\/CIRCULATIONAHA.104.486647","volume":"111","author":"S Windecker","year":"2005","unstructured":"Windecker S, Simon R, Lins M et al (2005) Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TINOX trial. Circulation 111:2617\u20132622","journal-title":"Circulation"},{"key":"285_CR27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/erd.10.44","volume":"7","author":"P Karjalainen","year":"2010","unstructured":"Karjalainen P, Ylitalo A, Airaksinen J, Nammas W (2010) Titanium-nitride-oxide-coated titan-2 bioactive coronary stent: a new horizon for coronary intervention. Expert Rev Med Devices 7:599\u2013604","journal-title":"Expert Rev Med Devices"},{"key":"285_CR28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCULATIONAHA.105.563403","volume":"113","author":"MK Hong","year":"2006","unstructured":"Hong MK, Mintz GS, Lee CW et al (2006) Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113:414\u2013419","journal-title":"Circulation"},{"key":"285_CR29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurheartj\/ehn553","volume":"31","author":"AK Hassan","year":"2010","unstructured":"Hassan AK, Bergheanu SC, Stijnen T et al (2010) Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J 31:1172\u20131180","journal-title":"Eur Heart J"},{"key":"285_CR30","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/CIRCULATIONAHA.109.906040","volume":"122","author":"N Guo","year":"2010","unstructured":"Guo N, Maehara A, Mintz GS et al (2010) Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial. Circulation 122:1077\u20131084","journal-title":"Circulation"},{"key":"285_CR31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jcmg.2012.08.007","volume":"5","author":"L Cortigiani","year":"2012","unstructured":"Cortigiani L, Rigo F, Gherardi S et al (2012) Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. JACC Cardiovasc Imaging 5:1079\u20131085","journal-title":"JACC Cardiovasc Imaging"},{"key":"285_CR32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/eurheartj\/ehs310","volume":"34","author":"L Cortigiani","year":"2013","unstructured":"Cortigiani L, Rigo F, Gherardi S et al (2013) Prognostic implication of Doppler echocardiographic derived coronary flow reserve in patients with left bundle branch block. Eur Heart J 34:364\u2013373","journal-title":"Eur Heart J"},{"key":"285_CR33","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/ehjci\/jes305","volume":"14","author":"L Ascione","year":"2013","unstructured":"Ascione L, Carlomagno G, Sordelli C et al (2013) Dipyridamole coronary flow reserve stratifies prognosis in acute coronary syndrome patients without left anterior descending disease. Eur Heart J Cardiovasc Imaging 14:858\u2013864","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"285_CR34","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/0735-1097(95)00359-2","volume":"26","author":"RS Beanlands","year":"1995","unstructured":"Beanlands RS, Muzik O, Melon P et al (1995) Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity. J Am Coll Cardiol 26:1465\u20131475","journal-title":"J Am Coll Cardiol"},{"key":"285_CR35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurheartj\/ehi571","volume":"27","author":"SH Hofma","year":"2006","unstructured":"Hofma SH, van der Giessen WJ, van Dalen BM et al (2006) Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 27:166\u2013170","journal-title":"Eur Heart J"},{"key":"285_CR36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacc.2005.01.062","volume":"46","author":"M Togni","year":"2005","unstructured":"Togni M, Windecker S, Cocchia R et al (2005) Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 46:231\u2013236","journal-title":"J Am Coll Cardiol"},{"key":"285_CR37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1253\/circj.71.220","volume":"71","author":"S Fuke","year":"2007","unstructured":"Fuke S, Maekawa K, Kawamoto K et al (2007) Impaired endothelial vasomotor function after sirolimus-eluting stent implantation. Circ J 71:220\u2013225","journal-title":"Circ J"},{"key":"285_CR38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.RES.0000233379.92010.fd","volume":"99","author":"BE St\u00e4hli","year":"2006","unstructured":"St\u00e4hli BE, Camici GG, Steffel J et al (2006) Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circ Res 99:149\u2013155","journal-title":"Circ Res"},{"key":"285_CR39","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1161\/CIRCULATIONAHA.105.569129","volume":"112","author":"J Steffel","year":"2005","unstructured":"Steffel J, Latini RA, Akhmedov A et al (2005) Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design. Circulation 112:2002\u20132011","journal-title":"Circulation"},{"key":"285_CR40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/01.ATV.0000254677.12861.b8","volume":"27","author":"JA Muldowney 3rd","year":"2007","unstructured":"Muldowney JA 3rd, Stringham JR, Levy SE et al (2007) Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents. Arterioscler Thromb Vasc Biol 27:400\u2013406","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"285_CR41","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","volume":"27","author":"AV Finn","year":"2007","unstructured":"Finn AV, Nakazawa G, Joner M et al (2007) Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27:1500\u20131510","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-013-0285-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-013-0285-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-013-0285-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:13:33Z","timestamp":1559222013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-013-0285-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,31]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["285"],"URL":"https:\/\/doi.org\/10.1007\/s10554-013-0285-8","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,31]]}}}